These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31227806)

  • 21. FBN1 gene mutations in 26 Hungarian patients with suspected Marfan syndrome or related fibrillinopathies.
    Madar L; Szakszon K; Pfliegler G; Szabó GP; Brúgós B; Ronen N; Papp J; Zahuczky K; Szakos E; Fekete G; Oláh É; Koczok K; Balogh I
    J Biotechnol; 2019 Aug; 301():105-111. PubMed ID: 31163209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Identification of a novel FBN1 variant in a pedigree affected with Marfan syndrome].
    Rong J; Dong S; Wang C; He S; Luo J; Li M; Deng Q; Yan M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Nov; 36(11):1107-1110. PubMed ID: 31703137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Legacy Genetic Testing Results for Cancer Susceptibility: How Common are Conflicting Classifications in a Large Variant Dataset from Multiple Practices?
    Yin K; Liu Y; Lamichhane B; Sandbach JF; Patel G; Compagnoni G; Kanak RH; Rosen B; Ondrula DP; Smith L; Brown E; Gold L; Whitworth P; App C; Euhus D; Semine A; Dwight Lyons S; Lazarte MAC; Parmigiani G; Braun D; Hughes KS
    Ann Surg Oncol; 2020 Jul; 27(7):2212-2220. PubMed ID: 32342295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Qualitative and quantitative analysis of FBN1 mRNA from 16 patients with Marfan Syndrome.
    Tjeldhorn L; Amundsen SS; Barøy T; Rand-Hendriksen S; Geiran O; Frengen E; Paus B
    BMC Med Genet; 2015 Dec; 16():113. PubMed ID: 26684006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How human genetic context can inform pathogenicity classification: FGFR1 variation in idiopathic hypogonadotropic hypogonadism.
    Xu W; Plummer L; Seminara SB; Balasubramanian R; Lippincott MF
    Hum Genet; 2023 Nov; 142(11):1611-1619. PubMed ID: 37805574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of the FBN1 gene in a cohort of patients with Marfan Syndrome: A 10-year single center experience.
    Mannucci L; Luciano S; Salehi LB; Gigante L; Conte C; Longo G; Ferradini V; Piumelli N; Brancati F; Ruvolo G; Novelli G; Sangiuolo F
    Clin Chim Acta; 2020 Feb; 501():154-164. PubMed ID: 31730815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wide mutation spectrum and frequent variant Ala27Thr of FBN1 identified in a large cohort of Chinese patients with sporadic TAAD.
    Guo J; Cai L; Jia L; Li X; Xi X; Zheng S; Liu X; Piao C; Liu T; Sun Z; Cai T; Du J
    Sci Rep; 2015 Aug; 5():13115. PubMed ID: 26272055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants.
    Huang H; Hu C; Na J; Hart SN; Gnanaolivu RD; Abozaid M; Rao T; Tecleab YA; Pesaran T; Lyra PCM; Karam R; Yadav S; Domchek SM; de la Hoya M; Robson M; Mehine M; Bandlamudi C; Mandelker D; Monteiro ANA; Boddicker N; Chen W; Richardson ME; Couch FJ
    bioRxiv; 2023 Dec; ():. PubMed ID: 38168194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic evaluation of gene variants linked to hearing loss based on allele frequency threshold and filtering allele frequency.
    Rim JH; Lee JS; Jung J; Lee JH; Lee ST; Choi JR; Choi JY; Lee MG; Gee HY
    Sci Rep; 2019 Mar; 9(1):4583. PubMed ID: 30872718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines.
    Ghosh R; Oak N; Plon SE
    Genome Biol; 2017 Nov; 18(1):225. PubMed ID: 29179779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.
    Luo X; Feurstein S; Mohan S; Porter CC; Jackson SA; Keel S; Chicka M; Brown AL; Kesserwan C; Agarwal A; Luo M; Li Z; Ross JE; Baliakas P; Pineda-Alvarez D; DiNardo CD; Bertuch AA; Mehta N; Vulliamy T; Wang Y; Nichols KE; Malcovati L; Walsh MF; Rawlings LH; McWeeney SK; Soulier J; Raimbault A; Routbort MJ; Zhang L; Ryan G; Speck NA; Plon SE; Wu D; Godley LA
    Blood Adv; 2019 Oct; 3(20):2962-2979. PubMed ID: 31648317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss.
    Patel MJ; DiStefano MT; Oza AM; Hughes MY; Wilcox EH; Hemphill SE; Cushman BJ; Grant AR; Siegert RK; Shen J; Chapin A; Boczek NJ; Schimmenti LA; Nara K; Kenna M; Azaiez H; Booth KT; Avraham KB; Kremer H; Griffith AJ; Rehm HL; Amr SS; Tayoun ANA;
    Genet Med; 2021 Nov; 23(11):2208-2212. PubMed ID: 34230634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA variant classification-reconsidering "allele rarity" and "phenotype" criteria in ACMG/AMP guidelines.
    Davieson CD; Joyce KE; Sharma L; Shovlin CL
    Eur J Med Genet; 2021 Oct; 64(10):104312. PubMed ID: 34411772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Two Novel Intronic Variants Affecting
    Fusco C; Morlino S; Micale L; Ferraris A; Grammatico P; Castori M
    Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31185693
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants.
    Tricarico R; Kasela M; Mareni C; Thompson BA; Drouet A; Staderini L; Gorelli G; Crucianelli F; Ingrosso V; Kantelinen J; Papi L; De Angioletti M; Berardi M; Gaildrat P; Soukarieh O; Turchetti D; Martins A; Spurdle AB; Nyström M; Genuardi M;
    Hum Mutat; 2017 Jan; 38(1):64-77. PubMed ID: 27629256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homozygous and compound heterozygous mutations in the FBN1 gene: unexpected findings in molecular diagnosis of Marfan syndrome.
    Arnaud P; Hanna N; Aubart M; Leheup B; Dupuis-Girod S; Naudion S; Lacombe D; Milleron O; Odent S; Faivre L; Bal L; Edouard T; Collod-Beroud G; Langeois M; Spentchian M; Gouya L; Jondeau G; Boileau C
    J Med Genet; 2017 Feb; 54(2):100-103. PubMed ID: 27582083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Three Novel FBN1 Mutations and Their Phenotypic Relationship of Marfan Syndrome.
    Kayhan G; Ergun MA; Ergun SG; Kula S; Percin FE
    Genet Test Mol Biomarkers; 2018 Aug; 22(8):474-480. PubMed ID: 30048161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-evaluation of missense variant classifications in NF2.
    Sadler KV; Rowlands CF; Smith PT; Hartley CL; Bowers NL; Roberts NY; Harris JL; Wallace AJ; Evans DG; Messiaen LM; Smith MJ
    Hum Mutat; 2022 May; 43(5):643-654. PubMed ID: 35332608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reinterpretation of common pathogenic variants in ClinVar revealed a high proportion of downgrades.
    Xiang J; Yang J; Chen L; Chen Q; Yang H; Sun C; Zhou Q; Peng Z
    Sci Rep; 2020 Jan; 10(1):331. PubMed ID: 31942019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel FBN1 variations implicated in congenital scoliosis.
    Lin M; Zhao S; Liu G; Huang Y; Yu C; Zhao Y; Wang L; Zhang Y; Yan Z; Wang S; Liu S; Liu J; Ye Y; Chen Y; Yang X; Tong B; Wang Z; Yang X; Niu Y; Li X; Wang Y; Su J; Yuan J; Zhao H; Zhang S; Qiu G; ; Ikegawa S; Zhang J; Wu Z; Wu N
    J Hum Genet; 2020 Mar; 65(3):221-230. PubMed ID: 31827250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.